Lucia Dipaola

Lucia Dipaola

Auto-generated profile, based on publicly available information

Lucia Dipaola

Clinical Physiology Institute, National Research Council of Italy (IFC-CNR), Lecce, Italy

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2015 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
Teresa CirilloTeresa Cirillo
Teresa Cirillo
GLGiuseppe Latini
Giuseppe Latini
MCMaria Antonietta Castaldi
Maria Antonietta Castaldi
LDLucia Dipaola
Lucia Dipaola
EFEvelina Fasano
Evelina Fasano
LCLuigi Cobellis
Luigi Cobellis

7 October 2009 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
PPPrisco Piscitelli
Prisco Piscitelli
FGF. Gimigliano
F. Gimigliano
SGS. Gatto
S. Gatto
AMA. Marinelli
A. Marinelli
AGA. Gimigliano
A. Gimigliano
GIGiovanni Iolascon
Giovanni Iolascon

1 January 2005 in Journal of Perinatal Medicine
Verified
Journal Article
Closed access
EREnrico Rosati
Enrico Rosati
GCGiovanna Chitano
Giovanna Chitano
LDLucia Dipaola
Lucia Dipaola
CFClaudio De Felice
Claudio De Felice
GLGiuseppe Latini
Giuseppe Latini
Critical congenital cardiovascular malformations (CCVMs) require surgical correction during the first month of life, physical examination is unable to detect >50% of affected infants. An oximetry screening has been previously proposed. Our aim was to verify the usefulness and consistency of a pulse oximetry screening for early detection of CCVMs in a small size nursery. A single determination of SpO2 was performed on 5292 consecutive apparently healthy newborns, discharged from nursery at a median age of 72 h during the period May 1, 2000 and November 30, 2004. Infants showing signs of congenital heart disease before the screening and those with a prenatal diagnosis were excluded. Cardiac ultrasound was performed on all infants with SpO2< or =95% at >24 h. The accuracy of the screening in identifying CCVMs was assessed by receiver-operating characteristic (ROC) curves analysis. We found 2 (0.038%) true positives, 1 (0.019%) false negative, 1 (0.019%) false positive, and 5288 (99.92%) true negatives. Prevalence of critical CCVMs was 1 in 1764. Clinical follow-up showed no evidence of CCVMs in the negative cases. A pulse-oximetry cut-off value of < or =95% showed 66.7% sensitivity (95% CI: 11.6-94.5), 100% specificity (95% CI: 99.9-100.0), 50% positive predictive value, 100% negative predictive value and AUC of 0.833 (standard error: 0.145) (95% CI: 0.823 to 0.843) in identifying CCVMs. Our findings indicate that pulse oximetry is a non-invasive and specific screening tool for an early detection of CCVMs, and is easily applicable to a small size nursery.

6 May 2005 in Gut
Verified
Journal Article
Open access
PDF file
CFClaudio De Felice
Claudio De Felice
SPSTEFANO PARRINI
STEFANO PARRINI
GCG Chitano
G Chitano
MGM Gentile
M Gentile
LDL Dipaola
L Dipaola
GLG Latini
G Latini
Background: Germline mutations in mismatch repair (MMR) genes are found in only about half of clinically diagnosed families with hereditary non-polyposis colorectal cancer syndrome (HNPCC) (or Lynch syndrome). Early identification of gene carriers is essential to reduce cancer incidence and overall mortality. Aims: Recent evidence indicates an increase in size and number of sebaceous glands following activation of the hedgehog pathway, a crucial signalling pathway for animal development that is aberrantly activated in several types of cancer. Here we sought to assess a possible association between Fordyce granules (FGs—that is, ectopic sebaceous glands on the oral mucosa) and HNPCC. Methods: A total of 15 members of five different genetically unrelated HNPCC kindreds ( MLH1 gene mutation n = 8; undetectable MLH1 protein at immunochemistry n = 4; clinical diagnosis n = 3) and 630 genetically unrelated age and sex matched healthy controls were examined. Following examination of the oral mucosa surface, subjects were categorised as either FGs positive or FGs negative. Results: Evidence of FGs was significantly associated with HNPCC (13/15 (86.7%) affected patients v 6/630 (0.95%) controls; p<0.0001), with a relative risk of 91.0 (95% confidence interval 40.05–206.76). The observed difference remained significant when carriers of germline mutations in MMR genes were considered (8/15 v 6/630; p<0.0001). The most common site for the FGs in HNPCC patients was the lower gingival and vestibular oral mucosa. Conclusions: Our findings suggest that a previously unrecognised activation of the sebaceous glands system occurs in HNPCC. The observation could be of value for attending physicians in identifying affected families and/or increase the accuracy of the currently available molecular genetics screenings.

1 August 2004 in Annals of Oncology
Verified
Journal Article
Closed access
PDF file
MBM. Bruno
M. Bruno
STStefania Tommasi
Stefania Tommasi
BSB. Stea
B. Stea
MQM. Quaranta
M. Quaranta
FSF. Schittulli
F. Schittulli
APAngelo Paradiso
Angelo Paradiso
Background: Before starting a molecular screening program for breast cancer risk and in order to develop ad hoc educational strategies, a population survey in Apulia, Italy, was performed to gather information on women's awareness of breast cancer genetics and their attitude toward genetic testing for breast cancer risk. Patients and methods: A consecutive series of 677 healthy women with or without a family history of breast cancer, who attended the outpatient clinics of Lega Italiana per la Lotta contro i Tumori in Bari, Italy, for preventive visits, were asked to complete a 20-item questionnaire on socio-demographics, risk perception, psychological characteristics and interest in genetic testing for breast cancer predisposing genes. Results: Most women (77%) reported knowing something about the genetics of breast cancer; only 7% of the women were not interested at all in genetic testing. These figures were not significantly different for women with or without a family history of breast cancer. The two most frequently cited reasons for being interested in genetic testing, accounting for more than 50% of collected responses, were ‘to learn about your children's risk’ and ‘to help advance research’. On multiple logistic regression analysis, only older age [odds ratio (OR) 1.9; 95% confidence interval (CI) 1.3–2.9] was associated with women's knowledge of genetic testing. Moreover, marital status (OR 4.0; 95% CI 1.1–14.6) and thinking of cancer (OR 2.2; 95% CI 1.0–4.7) independently predicted the interest in having genetic testing. Conclusions: Southern Italian women seem highly interested in genetic testing for breast cancer risk. However, their expectations mainly regard their concerns about their children or their altruistic need to help research rather than the idea of a direct clinical benefit. The great interest of the women in genetic testing probably reflects their inappropriate knowledge of the information that genetic testing can provide for breast cancer risk analysis.

22 October 2011 in Neonatology
Verified
Journal Article
Closed access
GLGiuseppe Latini
Giuseppe Latini
LDLucia Dipaola
Lucia Dipaola
CFClaudio De Felice
Claudio De Felice
Background: The perfusion index (PI), derived from the pulse oximetry signal, has been shown to be an accurate predictor for identifying high illness severity in neonates. The plethysmographic variability index (PVI) is a measure of the dynamic change in PI occurring during a complete respiratory cycle. Objectives: The aim of this study was to establish the reference range of PVI in spontaneously breathing term newborns. Methods: PI and PVI values were assessed in 242 term newborns during the first day of life. Results: The median PVI value on the first day of life was 20% [95% confidence interval (CI) for the mean 19–20%; inter-quartile range 15 (95% CI 15–16) – 24 (95% CI 23–24)]. The 10th and 90th percentile cutoff values were 12% (95% CI 11–12) and 28% (95% CI 27–29), respectively, with the 97.5th percentile of 35% (95% CI 34–38). PVI was also significantly influenced by the behavioral status of the newborn, and was positively correlated with PI and pulse rate, while it was inversely correlated with oxygen saturation (p < 0.0001). Conclusions: Our findings suggest: (1) evaluation of PVI values is an easily applicable, noninvasive procedure for monitoring early postnatal respiratory changes in newborns, and (2) the feasibility of a noninvasive pulse-oximeter postnatal screening for early identification of adverse neonatal cardiorespiratory outcomes.